News & Media
Stay up to date with the latest press releases, media coverage, and company updates from Vyome Holdings.
Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW)
Sep 4, 2025
Vyome Announces Strategic Review of Livechain (OTCID: LICH)
Aug 18, 2025
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell
Aug 15, 2025
Vyome Closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
Aug 14, 2025
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
Aug 13, 2025
Vyome Announces New Board of Directors with Deep MIT and AI Ties
Aug 12, 2025
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
Aug 7, 2025
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
Jul 24, 2025
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025
Jul 21, 2025
ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys
Jun 26, 2025
